The Glivec (imatinib) story begins with 2 Philadelphia researchers: Peter Nowell, MD, of the University of Pennsylvania School of Medicine, and David Hungerford, MD, of the Institute for Cancer Research. They were able to identify a genetic mutation in patients with CML (chronic myeloid leukaemia) in 1960.(1) The 2 researchers found that a section of DNA was missing from chromosome 22. This alteration soon became known as the Philadelphia (Ph) chromosome and could be detected in approximately 95% of patients with CML. The discovery meant that for the first time ever, scientists had discovered a genetic abnormality linked to a specific kind of cancer. The discovery of the link between the Ph chromosome and CML set off an explosion of research into the genetic causes of cancer.

--
Posted by Rob to CML Newswire: Medical And Technical News On Chronic Myelogenous Leukemia at 12/29/2005 01:18:56 AM


New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com

Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com

CML (Chronic Myelogenous Leukemia Support List)
---------------------------------
Part Of CMLHope.Com
An International Community Of CML Patients
For more information: http://cmlhope.com

Post Message: [email protected]
Subscribe:  [EMAIL PROTECTED]
Unsubscribe:  [EMAIL PROTECTED]
Change To No Mail/Web: [EMAIL PROTECTED]
Change To Digest: [EMAIL PROTECTED]
Change To Email: [EMAIL PROTECTED]
List Help: [EMAIL PROTECTED] 
CML Group Web Site http://groups.yahoo.com/group/CML




YAHOO! GROUPS LINKS




Reply via email to